SSA
AGTC

Schonfeld Strategic Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-23,400
Closed -$77K – 1630
2020
Q1 		$77K Buy
+23,400
New +$123K ﹤0.01% 1027
2016
Q4 		– Sell
-14,335
Closed -$140K – 676
2016
Q3 		$140K Buy
+14,335
New +$193K 0.02% 385

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Schonfeld Strategic Advisors's AGTC Position: Q2 2020 in Review

Schonfeld Strategic Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2020, closing a stake of 23,400 shares — an estimated $77K sold.

Schonfeld Strategic Advisors first reported a position in AGTC in Q3 2016 and held it in 2 quarters. The position peaked at $140K in Q3 2016. 65 funds tracked by Wall St. Rank hold AGTC as of Q2 2020.

  • Schonfeld Strategic Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q2 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 23,400 Applied Genetic Technologies Corporation shares in Q2 2020, an estimated $77K.
  • Schonfeld Strategic Advisors first reported a position in Applied Genetic Technologies Corporation in Q3 2016 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Applied Genetic Technologies Corporation position peaked at $140K in Q3 2016.
  • 65 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.